Matches in Nanopublications for { ?s ?p "[Plasma ACT might be used as a surrogate marker to monitor the conversion of pre-dementia stages to AD and the progression of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP280238.RAXpT3yfIMOqd9JtON5jSruuSPXC68kVy7tU-oJaHF2Yg130_assertion description "[Plasma ACT might be used as a surrogate marker to monitor the conversion of pre-dementia stages to AD and the progression of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP280238.RAXpT3yfIMOqd9JtON5jSruuSPXC68kVy7tU-oJaHF2Yg130_provenance.
- assertion description "[Plasma ACT might be used as a surrogate marker to monitor the conversion of pre-dementia stages to AD and the progression of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Plasma ACT might be used as a surrogate marker to monitor the conversion of pre-dementia stages to AD and the progression of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Plasma ACT might be used as a surrogate marker to monitor the conversion of pre-dementia stages to AD and the progression of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP334725.RALGzka1YBOMPi1iun_W2tdC6yjKiKgpkhbesmAy1Eh1Y130_assertion description "[Plasma ACT might be used as a surrogate marker to monitor the conversion of pre-dementia stages to AD and the progression of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP334725.RALGzka1YBOMPi1iun_W2tdC6yjKiKgpkhbesmAy1Eh1Y130_provenance.
- NP217923.RATmFF_MR9AD6xi2HI1Z3OVmZSb3Uv03MMXNdG8luEZnQ130_assertion description "[Plasma ACT might be used as a surrogate marker to monitor the conversion of pre-dementia stages to AD and the progression of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217923.RATmFF_MR9AD6xi2HI1Z3OVmZSb3Uv03MMXNdG8luEZnQ130_provenance.
- NP217829.RA4Jl4wxo-YhVzv0ZG7mSGyPqGrZQzp32fgUErXMOTnDs130_assertion description "[Plasma ACT might be used as a surrogate marker to monitor the conversion of pre-dementia stages to AD and the progression of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217829.RA4Jl4wxo-YhVzv0ZG7mSGyPqGrZQzp32fgUErXMOTnDs130_provenance.
- NP702232.RAi6UhrBu3YWovhLlIlqKALjJ4DM75H6NjFWjkiyalg6A130_assertion description "[Plasma ACT might be used as a surrogate marker to monitor the conversion of pre-dementia stages to AD and the progression of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP702232.RAi6UhrBu3YWovhLlIlqKALjJ4DM75H6NjFWjkiyalg6A130_provenance.
- NP702242.RA-yZY3UYlKnx38HCktjIdJFeIE4uGlbU1Cl84eqXRN9o130_assertion description "[Plasma ACT might be used as a surrogate marker to monitor the conversion of pre-dementia stages to AD and the progression of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP702242.RA-yZY3UYlKnx38HCktjIdJFeIE4uGlbU1Cl84eqXRN9o130_provenance.